You searched for Humanized antibody - Page 34 of 44

Weekly Roundup 8 Dec 2023

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

…pan‑immunoglobulin (Ig) G protease sculpting (Sc) enzyme candidate (S-1117) and a PD-1 agonist:Fc gamma receptor IIb selective Dual-cell Bidirectional (DcB) antibody candidate (S-4321). The fundraising will also allow Seismic to…

December 8, 2023 - 14 minutesmins - By Willow Shah-Neville

In Depth 28 Jul 2022

How can vaccines keep up with evolving Covid-19 variants?

…the spike antigen becomes. This makes the key target of the antibody response more subject to mutations,” said Alexandre Le Vert, executive chairman and co-founder of the French vaccine firm…

July 28, 2022 - 7 minutesmins - By Jonathan Smith

Isogenica Maverick Therapeutics llama antibodies cancer 1

News and Trends 7 Feb 2017

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

Isogenica has licensed its synthetic llama antibody library to Maverick Therapeutics, which develops cancer T-cell therapies designed to reduce side effects. Isogenica is a synthetic biology company near Cambridge that…

February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Jan 2017

This British Biotech is buying its way into the Crowded NASH Space

…fights inflammation by binding to the interleukin-6 receptor (IL-6R). Tiziana plans to use the antibody in combination with foralumab, an anti-CD3 antibody also licensed from Novimmune, for the treatment of…

January 4, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

lupus autoimmune disease neutrophil citryll

More News! 26 Nov 2019

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

…disease than current treatments in a phase III trial. The drug avacopan was trialed in 331 patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. This life-threatening condition is also known as ANCA…

November 26, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 4 Dec 2019

€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases

…use the money to fund the first phase I trial for its lead antibody immunotherapy for the treatment of various kinds of solid and liquid tumors. The trial is expected…

December 4, 2019 - 3 minutesmins - By Jonathan Smith

cancer treatments immuno oncology companies

News and Trends 23 Nov 2020

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

…Celleron Therapeutics last week with a huge Series A round of €37M. The fledgling company is developing an antibody drug that Celleron licensed from Roche in August to treat a…

November 23, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 15 May 2020

Update: ADC Therapeutics’ IPO Hits Above Target with €215M

…large B-cell lymphoma, and ultimately bring the drug to the US market. Lausanne-based ADC Therapeutics specializes in the development of antibody-drug conjugates, in which an antibody is attached to a…

May 15, 2020 - 4 minutesmins - By Laura Cowen

News and Trends 1 Jun 2023

Sanofi drug reduces disease activity in relapsing MS

New data, being presented in a late-breaking session at the 2023 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting, demonstrate that frexalimab, Sanofi’s novel second-generation investigational anti-CD40L antibody, with a…

June 1, 2023 - 4 minutesmins - By Jim Cornall

In Depth 30 Oct 2024

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

…different methods can be used, but generally speaking, it involves giving the patient a separate administration of another substance – whether that be an existing drug or a novel antibody,…

October 30, 2024 - 8 minutesmins - By Willow Shah-Neville

Best in Biotech 5 Dec 2017

Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017

…now has a blockbuster feather in its cap: its multiple myeloma antibody, Darzalex, reached over $1B (€850M) in sales in November. (Janssen has exclusive rights to it, so Genmab received…

December 5, 2017 - 6 minutesmins - By Evelyn Warner

News and Trends 19 Dec 2016

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

…an antibody targeting PGlu formation. So far, its Phase I clinical trials have returned encouraging data: patients receiving four injections over four months demonstrated a significant reduction in cognitive impairment….

December 19, 2016 - 7 minutesmins - By Evelyn Warner

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer

How can vaccines keep up with evolving Covid-19 variants?

British Synbio’s Llama Antibodies recruited for Cancer T-Cell Therapy

This British Biotech is buying its way into the Crowded NASH Space

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

€48M Series B Fuels Immunotherapies for Cancer and Autoimmune Diseases

SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’

Update: ADC Therapeutics’ IPO Hits Above Target with €215M

Sanofi drug reduces disease activity in relapsing MS

Could next-generation “switchable” CAR-T cells help improve the safety and efficacy of CAR-T therapies?

Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017

Following Eli Lilly’s Failure, what’s Next in Alzheimer’s Treatments?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!